Far East Drug Co. acquires majority stake in Singapore’s Fullerton Health

Fullerton Health Corporation Limited (Fullerton Health), a multinational occupational health care provider in the Asia-Pacific region, confirmed on Tuesday that pharmaceutical company Far East Drug (B.V.I.) Co. Ltd (FED) is acquiring a significant stake in the Singapore-headquartered group.

Fullerton founders charged with bribing insurer

The three founders of Asia-Pacific occupational health care provider Fullerton Healthcare have been charged for paying bribes to the (now former) CEO of insurance and professional services firm Aon Singapore. A regional source tells us this is an example of the risks that come with having a more free-wheeling private health sector.

Quadria investing $1.5bn into South and SE Asia

Singapore-based private equity firm Quadria Capital is set to inject $1.5bn worth of healthcare investments into South and South East Asian countries over the next two to three years. In line with growing trends, India stands to win big, earmarked to receive roughly 50% of the investment.

Interview: Edward Booty, CEO, reach52

HBI catches up with Edward Booty, CEO at Singapore based health platform Reach52, to find out about growth during a pandemic, the importance of primary care, and digital health solutions.

Deal activity bouncing back in SE Asia

Last week we wrote about an expected return to normal of M&A deal activity in Europe in Q2, after a slow few months driven by macroeconomic uncertainty. In South East Asia deal activity already appears to be returning to a healthier level, with multiple $1bn+ deals reportedly underway.

Key themes and takeaways from the IFC’s Emerging Markets conference

Last month, thought leaders from private healthcare systems across the globe gathered in Cape Town, South Africa, to network, share their findings, and consider how emerging markets can become more resilient. HBI was there, and these are our key themes and takeaways.

SE Asia’s pushes to primary care – but volumes and logistics are key

Providers in Southeast Asia have made a pronounced push towards primary care in recent years - but it hasn’t been all plain sailing with logistical challenges and high costs to contend with. Singapore and the Philippines are leading the way, as attendees at the recent IFC conference in Cape Town, South Africa, heard.

IHH Healthcare shows growth

Malaysia and Singapore based Asia-focussed IHH Healthcare’s 2021 results show dynamic growth. Turkish groups are being impacted by the depreciation of the lira, but while revenue from domestic patients in Turkish subsidiary Acibadem shrank between 2017 and 2020, it grew in 2021, up 16.9% year-on-year.

Virtus takeover could lead to M&A push in Europe

Australia-based listed fertility specialist Virtus Health, which also has a footprint in Ireland, Denmark, the UK and Singapore, is the subject of a takeover bid. HBI speaks to an operator source to find out more about the prospects of one of the largest international fertility groups delisting.

Find Us